FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer
November 15, 2022 at 06:16 AM EST
TheFDA granted accelerated approvalforImmunoGen Inc's(NASDAQ: IMGN) Elahere (mirvetuximab ...